PT-141 10mg

PT-141 10mg (Bremelanotide) is a synthetic peptide analogue of α-Melanocyte-Stimulating Hormone (α-MSH), supplied as a lyophilised powder for laboratory research use. It is selected within controlled environments for investigation into peptide structure, receptor interaction, and signalling pathways.

Classification: Bremelanotide (PT-141) — a synthetic cyclic heptapeptide analogue of α-MSH, structurally related to melanotan II.

Within laboratory settings, PT-141 (Bremelanotide) is studied for its interaction with melanocortin receptors, particularly MC3R and MC4R. Research applications focus on receptor binding activity, peptide stability, and signalling pathways associated with the melanocortin system under controlled experimental conditions.

This summary describes published preclinical and, where applicable, clinical research. It is not a medical claim and does not describe or endorse any human use of the compound as sold by Peptides UK 4U.

Preclinical and clinical research characterises bremelanotide as a melanocortin receptor agonist with preferential activity at MC3R and MC4R. Published studies explore central melanocortin signalling in the context of sexual-behaviour research in animal models. Presented here as research background.

This product is typically reconstituted using bacteriostatic water or a suitable sterile solvent within a controlled laboratory setting. All handling should be carried out by qualified professionals using appropriate sterile techniques and safety procedures.

Storage & stability

• Store in a cool, dry environment before reconstitution.
• For extended stability, storage at -20°C is recommended.
• Avoid repeated freeze-thaw cycles after reconstitution.

For reconstitution volumes and target working concentrations use our peptide calculator. We do not publish dosing protocols for human use.

Peptide Type

Synthetic melanocortin receptor agonist analogue

Scientific Name

Bremelanotide (PT-141), α-MSH analogue

Form

Lyophilised powder

Quantity

10mg

Purity

≥98% (subject to batch testing)

Appearance

White lyophilised powder

Solubility

Water soluble

Stability

Maintains integrity under controlled storage conditions

Manufacturing Standard

Produced in controlled laboratory environments

Certificate of Analysis: Available on request from our support team.

• Rosen RC et al., International Journal of Impotence Research 16(2):135–142 (2004)
• Molinoff PB et al., Annals of the NY Academy of Sciences 994:96–102 (2003) — PT-141 pharmacology

References are provided for educational context. Citation does not imply endorsement of any specific use.